Thymoma and thymic carcinomas.

@article{Scorsetti2016ThymomaAT,
  title={Thymoma and thymic carcinomas.},
  author={Marta Scorsetti and Francesco Leo and Annalisa Trama and Rolando Maria D'Angelillo and D. Serpico and Marianna Macerelli and Paolo Andrea Zucali and Gemma Gatta and Marina Chiara Garassino},
  journal={Critical reviews in oncology/hematology},
  year={2016},
  volume={99},
  pages={332-50}
}
Thymomas (Ts) and thymic carcinomas (TCs) are rare tumours of the mediastinum with an incidence rate of 1.7/million per year in Europe. Histological classification is based on rate of non-malignant-appearing thymic epithelial cells and proportions of lymphocytes (A, AB, B1, B2, B3, and C), while staging system concerns localisation of the involved areas. Surgery is the mainstay of treatment with a 10-year survival of 80%, 78%, 75%, and 42% for stages I, II, III and IV, respectively, with an R0… CONTINUE READING